Shengyan Xi

686 total citations
34 papers, 474 citations indexed

About

Shengyan Xi is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Shengyan Xi has authored 34 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Complementary and alternative medicine. Recurrent topics in Shengyan Xi's work include Pharmacological Effects of Natural Compounds (6 papers), Stress Responses and Cortisol (4 papers) and Cancer Mechanisms and Therapy (4 papers). Shengyan Xi is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Stress Responses and Cortisol (4 papers) and Cancer Mechanisms and Therapy (4 papers). Shengyan Xi collaborates with scholars based in China, Canada and Malaysia. Shengyan Xi's co-authors include Gerald Y. Minuk, Lifeng Yue, Yuewen Gong, Yanhui Wang, Xiaolan Lin, Yunhong Li, Ying Yang, Li Wu, Yuqiao Shen and Hua Xie and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Shengyan Xi

34 papers receiving 467 citations

Peers

Shengyan Xi
Jung‐Hyo Cho South Korea
Bin Han China
Nazanin Momeni Roudsari Iran
Zhen Hu China
Dongxiao Wang China
Weiwei Su China
Farhana Ferdousi Japan
Yangseok Kim South Korea
Hongfeng Quan China
Walaa Wadie Egypt
Jung‐Hyo Cho South Korea
Shengyan Xi
Citations per year, relative to Shengyan Xi Shengyan Xi (= 1×) peers Jung‐Hyo Cho

Countries citing papers authored by Shengyan Xi

Since Specialization
Citations

This map shows the geographic impact of Shengyan Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyan Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyan Xi more than expected).

Fields of papers citing papers by Shengyan Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyan Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyan Xi. The network helps show where Shengyan Xi may publish in the future.

Co-authorship network of co-authors of Shengyan Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyan Xi. A scholar is included among the top collaborators of Shengyan Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyan Xi. Shengyan Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Lin, Wanqing Yang, Shengyan Xi, et al.. (2024). Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice. Journal of Natural Medicines. 78(3). 633–643. 3 indexed citations
2.
3.
Wang, Yanan, Zheng Wang, Chunling Gao, et al.. (2024). Jianpi-Huatan-Huoxue-Anshen formula ameliorates gastrointestinal inflammation and microecological imbalance in chemotherapy-treated mice transplanted with H22 hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 16(10). 4209–4231. 5 indexed citations
4.
Huang, Xiaoqing, Qiongyun Chen, Yanyun Fan, et al.. (2023). Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism. Biomedicine & Pharmacotherapy. 159. 114300–114300. 27 indexed citations
5.
Yang, Jiaqi, David Sontag, Frank J. Burczynski, et al.. (2022). Comparison of growth features and cancer stem cell prevalence in intrahepatic and extrahepatic cholangiocarcinoma cell lines. Clinical and Experimental Hepatology. 8(1). 60–69. 2 indexed citations
6.
7.
Xi, Shengyan, Yanan Wang, Yuewen Gong, et al.. (2021). The Ciji-Hua’ai-Baosheng II Formula Attenuates Chemotherapy-Induced Anorexia in Mice With H22 Hepatocellular Carcinoma. Frontiers in Pharmacology. 12. 715824–715824. 10 indexed citations
8.
Xi, Shengyan, Ying‐Kun Qiu, Yumei Zhang, et al.. (2021). The Protective Effects of Zornia diphylla (L.) Pers. Against Acute Liver Injury Induced by Carbon Tetrachloride in Mice. Frontiers in Pharmacology. 12. 764282–764282. 4 indexed citations
9.
10.
Xi, Shengyan, et al.. (2020). Role of Traditional Chinese Medicine in the Management of Viral Pneumonia. Frontiers in Pharmacology. 11. 582322–582322. 36 indexed citations
11.
Yang, Ying, Li Wu, Ge Sun, et al.. (2020). Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China. Frontiers in Pharmacology. 11. 1066–1066. 69 indexed citations
12.
Zhuang, Wei, Xiaolan Lin, Bin Chen, et al.. (2020). Medication with caution: Analysis of adverse reactions caused by a combination of Chinese medicine and warfarin sodium tablets. Journal of Ethnopharmacology. 254. 112586–112586. 9 indexed citations
13.
14.
Xi, Shengyan, Yanhui Wang, Yanan Wang, et al.. (2019). The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis. Frontiers in Pharmacology. 9. 1539–1539. 8 indexed citations
15.
Xi, Shengyan & Gerald Y. Minuk. (2018). Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World Journal of Hepatology. 10(11). 799–806. 40 indexed citations
16.
Li, Weidong, Yan Zhu, Shakir M. Saud, et al.. (2017). Electroacupuncture relieves depression-like symptoms in rats exposed to chronic unpredictable mild stress by activating ERK signaling pathway. Neuroscience Letters. 642. 43–50. 30 indexed citations
17.
Xi, Shengyan, Lifeng Yue, Mengmeng Shi, et al.. (2016). The Effects of Taoren‐Honghua Herb Pair on Pathological Microvessel and Angiogenesis‐Associated Signaling Pathway in Mice Model of CCl4‐Induced Chronic Liver Disease. Evidence-based Complementary and Alternative Medicine. 2016(1). 2974256–2974256. 12 indexed citations
18.
Xi, Shengyan, Mengmeng Shi, Gerald Y. Minuk, et al.. (2016). The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease. Journal of Ethnopharmacology. 180. 28–36. 23 indexed citations
19.
Xi, Shengyan, Jia Huang, Dawei Lü, et al.. (2014). Effects of Ciji Hua’ai Baosheng Granule Formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapymodelmouse with H<sub>22</sub> hepatoma carcinomacells. African Journal of Traditional Complementary and Alternative Medicines. 11(4). 94–94. 12 indexed citations
20.
Xi, Shengyan, et al.. (2012). Effects of hydroxy safflower Yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice. Journal of Traditional Chinese Medicine. 32(2). 243–248. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung‐Hyo Cho Breakdown of academic impact, for papers by Bin Han Breakdown of academic impact, for papers by Nazanin Momeni Roudsari Breakdown of academic impact, for papers by Zhen Hu Breakdown of academic impact, for papers by Dongxiao Wang Breakdown of academic impact, for papers by Weiwei Su Breakdown of academic impact, for papers by Farhana Ferdousi Breakdown of academic impact, for papers by Yangseok Kim Breakdown of academic impact, for papers by Hongfeng Quan Breakdown of academic impact, for papers by Walaa Wadie
Rankless by CCL
2026